sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician's office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 20202022

Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and...

Home / Categories / Healthcare
Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician's office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 20202022
Covid-19 Diagnostics Market by Product...
Report Code
RO1/113/1699

Publish Date
25/Sep/2020

Pages
275
PRICE
$ 5769/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6450/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8995/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology

1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter's five forces analysis
3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Significant increase in incidences of COVID-19 infection
3.3.1.2.Unavailability of specific medicines/ vaccines

3.3.2.Restraints

3.3.2.1.Lack of COVID-19 diagnostic kits

3.3.3.Opportunity

3.3.3.1.Growth opportunities in emerging economies

3.4.Insights on antigen-based testing
3.5.Market share analysis

CHAPTER 4:COVID-19 DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Approved COVID-19 Diagnostic Products
4.1.2.Market size and forecast, by technology

4.2.Molecular assay

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region

4.3.Immunoassay/Serology

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region

CHAPTER 5:COVID-19 DIAGNOSTICS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast, by product

5.2.PCR Kits

5.2.1.Market size and forecast, by region

5.3.Immunoassay test

5.3.1.Market size and forecast, by region

5.4.POC (Point -of-care) test

5.4.1.Market size and forecast, by region

CHAPTER 6:COVID-19 DIAGNOSTICS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast, by end user

6.2.Hospitals

6.2.1.Market size and forecast, by region

6.3.Diagnostic laboratories

6.3.1.Market size and forecast, by region

6.4.Physician offices & urgent care clinics

6.4.1.Market size and forecast, by region

CHAPTER 7:COVID-19 DIAGNOSTICS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S. market size and forecast, by technology
7.2.2.2.U.S. market size and forecast, by product
7.2.2.3.U.S. market size and forecast, by end user
7.2.2.4.Canada market size and forecast, by technology
7.2.2.5.Canada market size and forecast, by product
7.2.2.6.Canada. market size and forecast, by end user
7.2.2.7.Mexico market size and forecast, by technology
7.2.2.8.Mexico market size and forecast, by product
7.2.2.9.Mexico. market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends
7.3.2.Market size and forecast, by country

7.3.2.1.France market size and forecast, by technology
7.3.2.2.France market size and forecast, by product
7.3.2.3.France market size and forecast, by end user
7.3.2.4.UK market size and forecast, by technology
7.3.2.5.UK market size and forecast, by product
7.3.2.6.UK. market size and forecast, by end user
7.3.2.7.Germany market size and forecast, by technology
7.3.2.8.Germany market size and forecast, by product
7.3.2.9.Germany market size and forecast, by end user
7.3.2.10.Spain market size and forecast, by technology
7.3.2.11.Spain market size and forecast, by product
7.3.2.12.Spain market size and forecast, by end user
7.3.2.13.Italy market size and forecast, by technology
7.3.2.14.Italy market size and forecast, by product
7.3.2.15.Italy market size and forecast, by end user
7.3.2.16.Austria market size and forecast, by technology
7.3.2.17.Austria market size and forecast, by product
7.3.2.18.Austria market size and forecast, by end user
7.3.2.19.Estonia market size and forecast, by technology
7.3.2.20.Estonia market size and forecast, by product
7.3.2.21.Estonia market size and forecast, by end user
7.3.2.22.Czech Republic market size and forecast, by technology
7.3.2.23.Czech Republic market size and forecast, by product
7.3.2.24.Czech Republic market size and forecast, by end user
7.3.2.25.Rest of Europe market size and forecast, by technology
7.3.2.26.Rest of Europe market size and forecast, by product
7.3.2.27.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country

7.4.3.1.Japan market size and forecast, by technology
7.4.3.2.Japan market size and forecast, by product
7.4.3.3.Japan market size and forecast, by end user
7.4.3.4.China market size and forecast, by technology
7.4.3.5.China market size and forecast, by product
7.4.3.6.China market size and forecast, by end user
7.4.3.7.India market size and forecast, by technology
7.4.3.8.India market size and forecast, by product
7.4.3.9.India market size and forecast, by end user
7.4.3.10.Australia market size and forecast, by technology
7.4.3.11.Australia market size and forecast, by product
7.4.3.12.Australia market size and forecast, by end user
7.4.3.13.South Korea market size and forecast, by technology
7.4.3.14.South Korea market size and forecast, by product
7.4.3.15.South Korea market size and forecast, by end user
7.4.3.16.Thailand market size and forecast, by technology
7.4.3.17.Thailand market size and forecast, by product
7.4.3.18.Thailand market size and forecast, by end user
7.4.3.19.Malaysia market size and forecast, by technology
7.4.3.20.Malaysia market size and forecast, by product
7.4.3.21.Malaysia market size and forecast, by end user
7.4.3.22.Rest of Asia-Pacific market size and forecast, by technology
7.4.3.23.Rest of Asia-Pacific market size and forecast, by product
7.4.3.24.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil market size and forecast, by technology
7.5.2.2.Brazil market size and forecast, by product
7.5.2.3.Brazil market size and forecast, by end user
7.5.2.4.South Africa market size and forecast, by technology
7.5.2.5.South Africa market size and forecast, by product
7.5.2.6.South Africa market size and forecast, by end user
7.5.2.7.Saudi Arabia market size and forecast, by technology
7.5.2.8.Saudi Arabia market size and forecast, by product
7.5.2.9.Saudi Arabia market size and forecast, by end user
7.5.2.10.Israel market size and forecast, by technology
7.5.2.11.Israel market size and forecast, by product
7.5.2.12.Israel market size and forecast, by end user
7.5.2.13.Rest of LAMEA market size and forecast, by technology
7.5.2.14.Rest of LAMEA market size and forecast, by product
7.5.2.15.Rest of LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.CELLEX INCORPORATED

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.CEPHEID

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.F. HOFFMANN-LA ROCHE LTD.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance.
8.4.6.Key strategic moves and developments

8.5.HOLOGIC, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.LABORATORY CORP OF AMERICA HOLDINGS

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.MYLABDISCOVERY SOLUTIONS PVT. LTD.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Key strategic moves and developments

8.8.QUEST DIAGNOSTICS INCORPORATED

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.SEEGENE INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments

8.10.THERMO FISHER SCIENTIFIC, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com